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ABSTRACT
Who Does R&D and Who Patents?
This paper describes the construction of a large panel dataset
covering about 2600 firms in the U.S. manufacturing sector forup to
twenty years which contains annual data on financial variables, employ-
ment, research and development expenditures, and aggregate patent
applications. This data set is to be used in a larger study of R&D,
inventive output, and technological change. In thepresent paper we
present preliminary results on the R&D and patenting behavior of the
1976 cross section of these firms. We find anelasticity of R&D with
respect to sales of close to unity, with both very small and very large
firms being slightly more R&D intensive thanaverage. Because only
sixty percent of the firms report R&D expenditures, we attempt to correct
for selectivity bias and find that although the correction issmall, it
increases the estimated complementarity between capitalintensity and
R&D intensity. In exploring the relationship of thepatenting activity
of these firms to their contemporaneous R&D expenditures,we look with
some care at the choice of econometric specification since the discrete
nature of the patents variable for our smaller firmsmay cause difficulties
with the conventional log linear model. The choice ofspecification
does indeed make a difference, and the negative binomial model, which
is a Poisson—type model with a disturbance, is preferred.Substantively,
we find a much larger output of patents per R&D dollar for the small
firms, with a decreasing propensity to patent with size of R&Dprograms
throughout the sample. However, this conclusion is highly tentative both
because of its sensitivity to specification and choice of sample and
also because we expect that the errors in variables bias due toour
focus on R&D and patent applications in a singleyear is far worse for
the small firms.
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WhO DOES R&D AND W1O PATENTS?
by
John Bound, Clint Curnmins, Zvi Griliches, Bronwyn 1-Tall, and Adam Jaffe
I. Introduction
As part of an on—going study of R&D, inventive output, and
productivity change, the authors are assembling a large data set for
a panel of U.S. firms with annual data from 1972 (or earlier) through
1978. This file will include financial variables, research and development
expenditures and data on patents. The goal is to have as complete a
cross section as possible of U.S. firms in the manufacturing sector
which existed in 1976, with time series information on the, same firms
for the years before and after 1976. This paper presents a preliminary
analysis of these data in the cross sectional dimension, to lay some ground
work for the future by exploring the characteristics of this sample and
describing the R&D and patenting behavior of the firms in it. It follows
on previous work on a smaller sample of 157 firms (see Pakes and Griliches
(1980) and Pakes (1981)).
In what follows we describe first the construction of our sample
from the several data sources available to us. Then we discuss the
reporting of our key variable,—2—
Research and Development expenditures, and relate this variable to
firm characteristics such as industry, size, and capital intensity.
An important issue here is whether the fact that many firms do not
report R&D expenditures will bias results based only on firms which do.
We attempt to correct for this bias using the well-known Heckman
(1976) procedure.
Section IV of the paper describes the patenting behavior of the
same large sample of firms. We attempt to quantify the relationship
between patenting, R&D spending, and firm size, and explore the
interindustry differences in patenting in a preliminary way. Due to the
many small firms in this data set, we pay considerable attention to the
problem of estimatibn when our dependent variable, patents, takes on
small integer values. The paper concludes with some suggestions for
future work using this large and fairly rich data set.-.3—
II. Sample Description
The basic universe of the sample is the set of firms in the
U.S. manufacturing sector which existed in 1976 on Standard and Poor's
Compustat Annual Industrial Files. The source of data for these tapes is
company reports to the S.E.C., primarily the 10—K report, supplemented
by market data from such sources as NASDAQ and occasionally personal
communication with the company involved. The manufacturing sector is
defined to be firms in the Compustat SIC groups 2000—3999 andconglomerates
(SIC 9997)1
Company data was taken from four Compustat tapes. The Industrial
File includes the Standard and Poor 400 companies, plus all othercompanies
traded on the New York and American Stock Exchanges. The Over The Counter
(OTC) tape includes companies traded over the counter that command significant
investor interest. The Research Tape includes companies deleted from
other files because of acquisition, merger, bankruptcy, etc.Finally,
the Full Coverage tape includes other companies which file 10—K's,
including companies traded on regional exchanges, wholly owned subsidiaries
and privately held companies. From these tapes we obtained data on the
capital stock, balance sheets, income statements including such expense
items.as Research and Development expenditures, stock valuation and
dividends, and a few miscellaneous variables such as employment.
Unfortunately, our patent data does not come in a form which can
be matched easily at the firm level. Owing to the computerization—4—
of the U.S. Patent Office in the late 1960's, we are able to obtaina file
with data on each individual patent granted by the Patent Office from 1969
through 1979. For each such patent we have theyear it was applied for,
the Patent Office number of theorganization to which it was granted,
an assignment code telling whether the organization isforeign or domestic,
corporate or individual, and some information on the product fieldand SIC
of the patent. We also have a file ofcorrespondences between Patent
Office organization numbers and thenames of these organizations. The
difficulty is that these patenting organizations,although frequently
corporations in our sample, may also be subsidiaries ofour firms, or have
a slightly different name from that given on theCompus tat files ("Co."
instead of "Inc." or "Incorporated", and other suchchanges or abbreviations).2
Thus, the matching of the Patent Office file with theCompustat data is
a majpr task in our sample creation.
To do the matching, we proceeded as follows: all firms inthe final
sample (about 2700) were looked up in the Dictionary of Corporate
Affiliations (1976) and their names as well as thenames of their
subsidiaries were entered in a data file to be matchedby a computer
program to the names on the Patent Office organization file. This
program had various techniques, for accommodating differences inspelling
and abbreviations. The matched list ofnames which it produced was
checked for incorrect matches manually and a final filewas produced which related
the Compustat identifying CUSIP number ofour firms to one or more—5—
(in some cases, none) Patent Office organization numbers.Using this
file, we aggregated the file with individualpatent records to the
firm level. At the time of the writing of thispaper we are engaged in
a reverse check of the matching process which involves looking at the
large patenting organizations which are recorded as domestic U.S.
corporations, but which our matching program missed. The results of
this check may further increase some of our patent totals.
In assembling this data set we have attempted to confine thesample
to domestic corporations, since the focus of our researchprogram is
the interaction between Research and Development, technologicalinnovation,
and productivity growth within the United States. Inspection of the
Compustat files reveals that at least a few large foreign firms, mostly
Japanese, are traded on the New York Stock Exchange, consequently file
10—K's with the S.E.C., and would be included in our sample,although
their R&D is presumably primarily done abroad and their U.S.patents are
recorded as foreign—owned. In order to clean our sample of these firms,
we did several things: first, we were able to identify and delete all
firms which Compustat records as traded on the Canadian Stock Exchange.
Then we formed a ratio of foreign—held U.S.patents to total number of U.S.
patents for each firm in our sample. For most of our sample, this ratio
is less than fifteen percent; the list of firms for which it is larger
includes most of the American Deposit Receipts (ADR) firms on the New
York Stock Exchange and several other firms clearly identifiable as
foreign. After deleting these firms from the sample, as a final check
we printed a list of the remaining firms with 'ADR' or 'LTD' in their
names. There were 18 such firms remaining, which we deleted from the
sample.—6—
The firms which were left still had a few foreign—ownedpatents
(about two percent of the total number ofpatents in 1976), due to joint
ventures or foreign subsidiairies. Since their Compustat data is
consolidated and includes R&D done by these subsidiaries in the R&D
figure, we added those patents to the domestic patents to produce a
total successful patent application figure for the firm.
Our final 1976 cross section consists of data on sales, employment,
book value in various forms, pre—tax income, market value, R&D expenditures,
and patents applied for in 1976 for approximately 2600 firms in the
manufacturing sector. The selection of these firms is summarized in Table
1. Except for a few cases, firms without reported gross plant In 1976 are
firms which did not exist in 1976. Seventy—seven firms were deleted
because they were wholly owned subsidiaries of another company In our
sample, or duplicates among the Compustat files; another 31 had zero or
missing Sales or Cross plant. The final sample consists of 2595 firms,
of which 1492 reported positive R&D in 1976. In the next section of this
paper, we present some results on the R&D characteristics of these firms.—7—
Table 1
Creation of the 1976 Cross Section_
Positive GrossPositive
Plant & Sales R&D
in 1976; Not Dupli-
cates ,Subsidiaries
or Foreign
Compustat File Manufacturing Firms Gross Plant
on Compustat Tape Reported in
1976
Industrial 1299 1294 1248 770
OTC 489 472 458 292
Research 414 138 132 83




of Firms 3221 2770 2595 1492—8—
III.The Reporting of Research and Development Expenditures
In 1972, the SEC issued new requirements for the reporting
of R&D expenditures on Form 10—K. These requirements may be summarized
as mandating the disclosure of the estimated amount of R&D expenditures
when a) it was "material", b)it exceeded one percent of sales, gj
c) a policy of deferral or amortization of R&D expenses was pursued.
Acting on these new requirements, the Financial Accounting Standards
Board issued a new standard for the reporting of R&D expenditures in
June of 1974. UntIl this time, accepted accounting practices appear to
have allowed the amortizing of 1&D expenditures over a short time
period as an alternative to simple expensin but the new standard allows
only expensing (San Miguel and Ansari (1975)). Accordingly, we have reason to
believe that by 1976 most of our firms are reporting R&D expense
when it is "material" and that the expense reported has been incurred
that year.
For the purpose of this paper, we make no distinction among firms
whoseR&D is reported by Compustat as "not available", "zero", or
"not significant".3 All such firms are treated as not reporting positive
R&D.This is because of the nature of the SEC reporting requirements
for R&D, and the way Compustat handles company responses. As noted above,
companies are supposed to report "material" R&D expenditures. If the—9—
company and their accountants conclude that R&D expenditures were "not
material" (possibly zero but not necessarily so) they sometimessay so
in the 10—K report, in which case Compustat records "zero".4Alternatively,
the company may say nothing about R&D, in which case Compustat records
"not available". It is also likely that companies reported "not
available" include some which are "randomly" missing, i.e., thecompany
performs "material" R&D but for some reason Compustat could not get
•the number for that year.5
Another source of data on aggregate spending on R&D by U.S. industry
is the National Science Foundation, which reports total R&D spending in
the United States every year broken down into approximately 30 industry
groupings.These data are obtained from a comprehensive survey of U.S.
enterprises by the Industry Division of the Bureau of the Census, which
covers larger firms completely and samples the smaller firms. Although
there are several important differences between these data and that reported
by Compustat, it is of interest to compare the aggregate figures, which
we show in Table 2. The company R&D figures are the most directly comparable
to our Compustat numbers, but we show the figures for total R&D also since
NSF does not provide a breakdown between company—sponsored and
federal—sponsored R&D expenditures for many of the industries (to avoid
disclosing individual company data). There are several reasons for the
discrepancies between the Compustat and NSF total&. First, the industry—10—
Table 2












Industrialchemicals 1323 249 1074 1604
Drugs & medicines 1091 — — 1053
- Otherchemicals 602 — — 516-
Petroleumrefining &extraction 767 52 715 908
Rubberproducts 502 — — 346
Stone, clay & glass products i 263 — — 218
Primary metals
I506 26 481 302
Ferrous metals & products 256 4 252 151
Nonferrousmetals &products 250 22 229 151
Fabricatedmetal products 358 36 322 186
Machinery 3487 332 2955 2898
Office, computing, & 2402 509 1893 2035
—- accountingmachines- ——_______
Electricalequipment & communication 5636 2555 3081 2543
Radio & TV receiving equipment 32 0 52 119
Electronic components 691 — — 327
Communication equipment & 2511 1093 1418 231
communication
I
otherelectrical equipment 2382 — — 866
Motcr vehicles & motor vehicles 2778 383 2395 j2847
equipment
Other Transportation equipment 94 — — 54
Aircraft & missiles 6339
-4930 1409 851
Professional & scientific instrument 1298 155 1144 1195
Scientific & mechanical 325 6 318 315
measuring instruments
Optical, surgical, photographic 974 148 826
j 880
_______qtbexins.t.r_wnent& ______ - - --
Othermanufacturing 217 5 212 93
Conglomerates 563
Total manufacturing 26093 9186 16906 15470
Food & kindred products
Textiles and apparel
Lumber, wood products & furniture
Paper & allied products







Source: Research and Development in Industry, 1977, Surveys of Science Resources
Series, National Science Foundation, Publication Number 79—313.—11—
assignment of a company is not necessarily the same across the two sets
of data: the most striking difference is in the communications industry,
which includes AT&T in the NSF/Census sample, while AT&T is assigned to SIC
4800 on the Compustat files and is therefore not in our sample. Adding the 1976
R&D for AT&T and its subsidiary, Western Electric, to the Compustat communications
total would raise it to about one billion, not enough to account for the difference
There are also definitional differences between the Form 10-K R&D
and that in the Census survey. The 10—K includes international and
contracted—out R&D, while these are entered on a separate line of the
Census survey.6 The total amount involved is about 1.7 billion dollars
in 1976. This is likely to explain why our Industrial Chemicais figure is
•too high, for example. Some firms include engineering or product—testing
on one survey but exclude it on the other, apparently because the Census
survey is quite explicit about the definition of Research and Development,
while the 10—K allows considerably more flexibility. Finally, thecoverage
of firms in the U.S. manufacturing sector by Compustat is less complete
than by Census for two reasons: privately held firms are not required
to file Form 10—K, and there are some large firms which do file a 10—K,
but record their R&D as not "material", even though a positive figure is reported
to the Bureau of the Census.In spite of all these caveats the Compustat and
NSF numbers do seem to match fairly well across industries and the total is
within 15 percent after correcting for AT&T and the international and
contracted—out R&D.—12—
Table 3 presents some summary statistics for the firms in the
sample, broken down into 21 industry categories. The categories are
based approximately on the NSF applied R&D categories shown in Table 2,
with some aggregation, and the separation of the lumber, wood and paper and
consumer goods categories from miscellaneous manufacturing. The exact
industry category assignment scheme which we used throughout this paper,
based on SIC codes, is presented in Appendix A. A few firms with exceptionally
large or small R&D to sales ratios have been 'utrimmed'1 from the sample
in this table (see below for an exact definition of the criterion used).
As the table shows, the population of the industry categories and the
fraction of firms reporting R&D varies greatly, from 20 percent for the
miscellaneous category to above 80 percent for drugs and computers.
Table 4 shows the size distribution of firms in the sample. A large
number of small firms are included; there are about 70 firms with less
than a million dollars in sales, and over 600 with less than 10 million.
These firms, however, account for less than 1% of total sales of firms
in the sample. As might be expected, larger firms tend to report R&D
more often even though they do about the same amount as a fraction
of sales. This is shown graphically in Figure 1. Up until about




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Size Distribution of Firms
Size Class Number Number Percent ofPercent of Percent of
(Sales In 1976 of firms of firms firms Total Total R&D
Dollars) Reporting reporting Sales
R&D R&D
Less than 1 million 72 33 46 .003 .019
1 to 10 million 545 293 54 .23 .42
10 to 100 million 1097 575 53 4.1 3.4
100 million to 1 billion 663 412 62 19.1 14.8
1 to 10 billion 205 167 81 48.3 50.6
































































































































































































































































































































































































































































































































































but above 10 billion almost 90% do. Previous workers havesuggested
that this may be because bigcompanies are able to do their accounting
more carefully (San Miguel and Ansari (1975), but it is surprising
how big a company must be before it has a 75% probability ofreporting
R&D.
As we indicated above, the nature of SEC reporting rules results
in ambiguity in the interpretation of firms' reporting zero R&D or not
reporting R&D. This ambiguity has implications for the analysis of
the subsample of firms that do report R&D ("the R&D sample"). Although
we do not believe that the non—R&D sample firms all do zero R&D, it is
likely that they do less than the firms that report it. It is also
possible that they do less R&D than would be expected, given their
other characteristics such as industry, size and capital intensity.
If so, then their exclusion from regressions of R&D on firm characteris-
tics will result in biased estimates of the association of these charac-
teristics with the firms' propensity to do R&D.
To shed light on this problem, the distribution of reported R&D
was examined in several ways. First, if firms consider R&D expenditures
to be immaterial if they fall below some absolute amount, then the
distribution of R&D would be truncated from below. We find no evidence
of such truncation in the the R&D distribution. It is also possible that
R&D is considered immaterial if it is small relative to firm size.
This seems particularly likely because, in addition to the requirement
to report material R&D expenditures in Item l(b)(6) of the 10—K, the
SEC requires firms to report all expense categories that exceed one per—17—
cent of sales. Figure 2 is a histogram of R&D as percent of sales;
once again, no truncation is apparent. In fact, the mode of the
distribution occurs at about .3% of sales.
Although no obvious truncation was visible, either in absolute
magnitude or as a percent of sales, we cannot rule out the likely
possibility that a combination of cutoffs, both absolute and relative
(as interpreted by the firm's accountants) are in effect, implying
an indeterminate bias in the relationship of observed R&D to the firm's
characteristics. Therefore, we attempt to quantify the reporting—not
reporting of R&D with a Probit equation after presenting results for
the firms which do retort R&D.
In Figure 3 we show a plot of log R&D versus log Sales for
the R&D sample, which summarizes the basic relationship between R&D
and firm size in our data. It is apparent from this plot that the slope
and degree of curvature of this relationship are likely to be influenced
strongly by a few outlying points; some very small firms do large amounts
of R&D, and a few firms in the intermediate size range dovery little R&D.
To test for the sensitivity of the results to these few points, the sample
was trimmed by eliminating 7 firms (.5%) with lowest R&D/Sales ratio,
and 7 firms with the highest. The firms removed are those outside thediagonal
lines drawn on the plot. This reduces the mean ratio of R&D to sales
from 4.1% to 2.7%,, and the standard deviation from 35% to 3.8%. The effects
on the log—distribution are much less dramatic. The sirallest ratio
that was deleted from the upper tail was .716; the largest from the












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































the untrimmed distribution, whether it is viewed as normal or
(more plausibly) log—normal. Since the results with trimmed data
were not strikingly different from those with untrinmied data, we
present only one set of results for our regressions, using the trimmed data
throughout.
The first question we investigated in this sample was the nature of
industry variation in R&D performanee and the R&D—firm size relationship.
Equations of the form:
(1) logRa+SlogS + c
where R is R&D and S is Sales, were estimated separately for the
21 industries in Table 3.Except for the textile industry and miscellaneous
manufacturing, the estimated 13s were not statistically significantly different
from one another and the R—squares were above .65. The remainder of
the analysis was performed using uniform slope coefficients, whileallowing
for different industry intercepts by using industry dummies. Thiswas done
primarily for convenience, but it is not inconsistent with the individual
industry results. While such aggregation is in fact rejected by a
conventional F—test for the simple regression of log R&D on log Sales
(F(20,1437) =3.34),given the size of our sample, one should really use a
much higher critical value (about 8), in which case, one need not reject it.7—21—
After accepting the hypothesis of equality of the slope coefficients,
we estimated equations of the form:
(2) log R
S1logs+ 2 logA+ 53(logS)2 +y +c
whereR, and S are as previously defined: A =GrossPlant,
and y. are a set of industry intercepts. Simple statistics
on the regression variables are shown in Table 5 and basic regression
results in Table 6.
The first column in Table 6 gives the results of the simplest
regression. Although we know that this story is incomplete, this equation
indicates that there is almost no fall in R&D intensity with incrEasing firm
size.An analysis of variance using this equation and restrictions on it
is also interesting. Log Sales explains 73% of the total variance in
log R&D and 79%ofthe variance remaining after we control for the variations
inindustry means. Looked at the other way, the industry dummies explain
10%of the total variance and 30% of the variance remaining after we
control for log Sales.
The second column shows the effect of capital intensity on R&D intensity.
If we interpret this equation in terms of the equivalent regression of
log R&D on log Sales and log of the capital—sales ratio, we find it
implies a sales coefficient of .95, almost identical to that of the first
column, and a complementarity between capital intensity and R&D intensity
(coefficient of .24 for log (Gross Plant/Sales)). While this effect is
highly significant, its additional contribution to the fit is small.—22—
Table 5
ic!r Variables for the R&D Sample
(Number of Observations =1479)
Mean Standard Minimum* Maximum*
Deviation
LogR&D —0.15 2.19 $30Thousand$1.3Billion
LogSales 4.10 2.19 $79Thousand$49Billion
LogGrossPlant 2.99 2.43 $37Thousand$30Billion
R&D/Sales 0.026 0.038 0.00024 .57
*
Theantilogs of the extreina are shown for the first three variables.—23—
Table 6
jqg R&D Regression Estimates
Observationsl479
1 2 3 4
All SmallLarge
— Firms Firms Firms
Log Sales .965 .713 .684 .519 .576 .641
(.013) (.043) (.036) (.050)(.105) (.101)
Log Gross Plant .240 .187 .113 .187
(.039) (.039)(.074) (.046)
(Log Sales)2 .035 .031 .044 .020
(.004) (.004)(.052) (.008)
Standard Error .954 .942 .932 .925 .910
R2 .813 .818 .821 .824 .832
All regressions include 21 industry dummies, except that for small
firms, in which the Primary Metals and Conglomerate dummies
were dropped due to lack of firms.
There are 319 small firms (less than ten million dollars in sales) and
1160 large firms.—24—
The third and fourth columns in Table 6 indicate that there is significant
nonlinearity in the relationship between log R&D and log Sales. These
estimates imply that the elasticity of R&D with respect to sales varies
from .7 at sales of one million to 1.2 at sales of one billion. This
nonlinearity is also apparent in the scatter plot of log R&D and log Sales
presented in Figure 3. While a fairly linear relationship may exist
for large firms, it clearly breaks down for smaller firms. Thismay be
due at least in part to the selection bias discussed above; more will
be said below.
In the last two rows of Table 6 we present the results for the
fourth regression estimated separately for small firms (up to $10 million
in sales) and large firms (all others). The fit is improved slightly;
the F ratio for aggregation of the two subsamples is 3.29 (22,1433).
Allowing for differences in the slopes of log Sales and log Cross Plant
together diminishes the significance of the log Sales squared term,
particularly for the small firms.
Our measurement of the contemporary relationship between R&D and
sales may be a biased estimate of the true long—run relationship because
of the transitory component and measurement error in this year's sales,
particularly if we are interpreting sales as a measure of firm size.
To correct for this errors in variables bias, we obtained instrumental
variable estimates of a regression of log R&D on log Sales, log Sales
squared, and the industry dummies using log Cross Plant and its square
as instruments for the sales variables. The estimated coefficients were
.755 (.042) and .028 (.005) for log Sales and its square implying an
elasticity of R&D with respect to sales of .985 at the sample mean. This
compares to an elasticity of .972 for equation 3 in Table 6 and suggests
that the errors in variables bias, although probably present, is not
very lar2e in magnitude.—25—
As a first step in our attempts to correct for possible bias due
to non—reporting of R&D, we estimated a Probit equation whose dependent
variable was one when R&D was reported and zero otherwise. The model
underlying this equation is the following: the true regression model for
R&D is
(3) log R1 =
where is a vector of firm characteristics such
as industry and size and c.1 is a disturbance. We observe R when it is
larger than some (noisy) threshold value C., different for each firm.
This model is a variation of the generalized Tobit model, described by
many authors; this particular version is in Nelson (1974) and is equivalent to
a model described by Griliches, Hall, and Hausman (1978). C1 contains the
one percent of sales rule and anything else the firm uses to decide whether
R&D is "material", plus a stochastic piece,C2, which describes our
inability to predict exactly when a firm will report;
(4) C. =z.6 +. 1 1
In this framework, the probability of observing R&D may be expressed
as Prob (E —C> Z.6 —X.BjZ.,X.).If we assume C and £ are distributed 1 2 1i 11 1 2
jointly as multivariate normal, we get the standard Probit model
(5) Prob (R. observed) =1—F((Z.6—x.S)/a)—26—
where C is the variance of C1 — andF(.) is the cumulative normal
probability function. Since the Probit model is only identified up to a
scale factor, we can only estimate ó/c and /o. Deriving the model in
this way also sheds some light on what it is we are estimating when we
run a Probit on this data: presumably 1 and X. include many, if not
all, of the same variables. For example if the Z. were only log Sales and
the one per cent rule was being followed, the coefficient 6 would be unity
and if the true elasticity of R&D with respect to sales were also unity, the
Probit equation would yield a sales coefficient of zero. However, if
reporting depended only on the absolute amount of R&D performed, then
C. would be a constant and predicting large R&D would be equivalent to
predicting high reporting probability; this hypothesis implies that
the coefficients in the probit should be the same as those in the R&D
regression (up to a scale factor). Finally, if reporting depends in a
more complex way on industry and size of the firm, then there need be
no obvious relationship between the coefficients of the Probit model
and those of the regression.
The results of the Probit estimation are presented in Column 1
of Table 7. The coefficient on log sales is .016 (.05) compared to .52
(.05) in the comparable OLS equation for log R&D. At the mean of log sales
for the whole sample, the coefficient is .077. The coefficient
on log gross plant is reduced somewhat from OLS estimates. These results
suggest that the first of our two hypotheses above is closer to the truth:
R&D reporting depends primarily on R&D intensity and not on the absolute
level of R&D spending, with perhaps also a smaller effect due to firm
size.—27—
Table 7






Log Sales .016 (.051)
(Log Sales)2 .0018 (.0050)




.519 (.050) .536 (.050)
.031 (.004) .032 (.004)




All models contain industry dummies
1
These are the maximum likelihood estimates of the coefficients
in equation (5), the probability of R&D reporting. There are 2582
observations and 1479 report R&D. The X2 for the three variables besides
the industry dummies is 233.—28—
If it is true that the non—reporting firms are characterized
only by lower than average R&D as percent of sales, the OLS estimates
of "elasticities" presented earlier are not necessarily biased,
although the constant term and industry dummy coefficients could be.
Since it is also true, however, that the non—reporting firms are
smaller on average,8 the OLS elasticity estimates may be biased
downwards. This possibility was investigated using the procedure
popularized by I-leckman. For each observation with R&D reported, the
"inverse Mills ratio" was calculated as:
(7)
F(u)
where u is the argument of the Probit equation (Z.o —X)/c1evaluated
at this observation's data and the estimated Probit coefficients and
f(•) and F(•) are the standard normal density and cumulative distribution
functions respectively. When H is added to the OLS estimations, it
"corrects" for selectivity bias.—29—
A regression including the Mills ratio variable is presented in
column 3 of Table 7, together with the "uncorrected' estimates for
comparison. The coefficients on the Mills ratio is positive and significant
indicating the presence of selectivity bias. There is only a slight rise
in the sales coefficients, however, and the npnlinearity is about
the same. The largest increase is in the log Cross Plant coefficient,
which was also the best predictor of R&D reporting. Thus we would
underestimate the complementarity of capital intensity and R&D intensity
if we did not take into account the fact that non—capital—intensive firms
also tend to be those which do not report R&D expenditures.
It should be emphasized that in this application of the 1-]eckman
technique the Mills ratios are a nonlinear function of all the other
independent variables in the equation. This is because we have no variables
that predict reporting but not quantity of R&D. For this reason, the
incremental explanatory power of the M variable is due solely to the
nonlinearity of its relationship to the other variables in the model.
We know, however, that the dependence of R&D on these variables is likely
to be nonlinear to begin with. In the absence of a reporting predictor
that is excluded from the quantity equation, it is impossible to distinguish
selectivity bias and "true" nonlinearity in the R&D—size relationship.
This makes it impossible to draw a definitive conclusion regarding the
possibility of bias in the OLS estimates.—30-
IV. Patenting
The matching project described in the first section of this
paper yielded 4,553 patenting entities which were matched to the companies
in our sample. 1754 of our 2582 companies were granted at leastone patent
during the 1965—79 period, but only about sixty percent of that number
applied for a patent in 1976. Firms with R&D programs are far more
likely to apply for patents: about twenty percent of the firms with zero
or missing R&D have at least one patent in 1976, but this fraction rises
rapidly with size of R&D program until well over ninety percent of firms
with R&D larger than ten million dollars have patents in 1976.
If we look at the size of the finn rather than the R&Dprogram,
twenty—eight percent of the small firms (less than ten million in sales)
applied for a patent in contrast to the fifty—three percent which reported
R&D, but this difference is due primarily to the integer nature of the
patents data: when we consider all years rather than just 1976, the
percentage who patent rises to sixty. These same small firms account for
4.3% of sales, 3.8% of R&D, but 5.7% of patents in our sample. However,
the latter number may be an overestimate since we know that approximately
one—third of all domestic corporate patents remain unmatched in 1976
in our sample, and it is likely that some of these belong to subsidiaries
of our larger companies which we have overlooked. Further checking
of these patents is being done.
In Table 3 we show the mean number of patents and number of firms
which have one or more patents for each of our 21 industry classes.
As we expect, patenting is higher in the science—based or technological—31—
industries, both in terms of the fraction of firms which patent and the
average number of patents taken out by the patenting firms. The industries
with more than twenty—five patents per firm are chemicals, drugs,
petroleum, electrical equipment, engines, computers, motor vehicles,
and conglomerates. Presumably petroleum, motor vehicles,
and conglomerates appear on this list partly because of theaverage size
of the firms in those industries. On the other hand, the scientific
instrument and the machinery industries have a large number of patents
per R&D dollar but are composed of relatively small firms.
Earlier studies by Fakes and Criliches (1980) on a sample of 157
large U.S. manufacturing firms showed a strong contemporaneous relationship
between patent applications and R&D expenditures across firms in several
industries, and they suggested that patents are a fairly good indicator
of the investive output of the research department of a firm. We consider
the relationship again in Figure 4. Because of the large size range
of our firms, the patents R&D relationship will be obscured by the
simple correlation between number of patents and size of firm. Therefore,
we plot the log of patents normalized by gross plant versus the log of
R&D normalized by the same quantity for the firms which both do R&D
and patent. The number of firms shown is 831, about one—third of our
sample. The plot shows a strong correlation between patenting and R&D
for these firms with a slope slightly greater than one and a hint of
nonlinearity intherelationship(increasing slope for higher
R&D). There is considerable variance: the range of patents per million
dollars of R&D for the firms which patent is from about one—seventh of
a patent to ninety patents. The typical firm has a ratio of about two,






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































This picture is slightly misleading, however, since itcovers only
one—third of our sample. Accordingly, when we turn tomodelling the
relationship, we want to include the zero observations on both patents
and R&D in our estimation. We attempt to solve this problem intwo ways:
first we set log patents to zero for all zeropatent observations and allow
those firms to have a separate intercept (PATDU}1) in ourregressions,
as suggested by Pakes and Griliches. It should be emphasized that there
are about 1700 such observtions, which suggests that the significance
level of our estimates needs to be interpreted with caution. The
estimates we obtain imply that the observations with no patents have an
expected value of about one—half of a patent. Secondly, we model the
patents properly as a counts (Poisson) variable, taking on values 0, 1, 2,
etc., as suggested by Hausrnan, Hall, and Griliches (1981). In this case,
with the many small and few very large observations which we have, the
Poisson model turns out to give quite different results from the logarithmic
OLS model.
The first column of Table 8 displays the results of a regression of
log patents on log R&D expenditures, dummies for zero or missing R&D and
patents, and our 21 industry dummies. The estimate of the log R&D coefficient
is considerably lower than the comparable estimates by Pakes and Griliches
(1980), .61 (.08), or by 1-lausman, Hall, and Griliches (1981), .81 (.02).
The difference could be attributed to the size range of firms in our sample
which is far greater than in the earlier work and also to the large number
of zeroes in our variables. For comparison, the coefficient of log R&D is




Ii 2 3 4—
LogR&D .38 (.01) .37 (.008).37 (.008) .32 (.010)
Log Gross Plant
.064 (.008)
Log R&D Squared .083 (.002) .084 (.002) .081 (.002)
PATDUN -.79 (.04) —.82 (.03)—.85 (.03) —.76 (.03)
Other Variables Included RNDDtJM, RNDDUM, RNDDUM, RNDDUN
industry industry intercept industry dummies dummies dummies
Standard Error .713 .589 .595 .583
R2 .653 .763 .756 .768
Log Likelihood
Test for Industry Dummies =3.5—35—
of this last sample of firms with the Pakes and Griliches sample is
about 100 firms out of 831 and it consists primarily of the larger firms
from the complete sample. We will return to the question of how to handle
the enormous size range of our complete sample after we discuss the
Poisson and negative binomial results for this model.
The industry dummies from the regression in the first column of
Table 8 are a measure of the average propensity to patent in the particular
industry, holding R&D expenditures constant. Relative to the overall
mean, the industries with significantly higher than average patenting
propensity are chemicals, drugs, petroleum, engines, farm and construction
machinery, electrical equipment, aircraft, and the conglomerates.
Several industries which are highly technology—based such as
communications equipment and computers do not seem to patent any more
than the average: in fact, a finn in the computer industry has eighty—five
percent of the patents of an average firm doing the same amount of R&D.
To allow for possible nonlinearity in the patenting—R&D relationship
we add the log of R&D expenditures squared to the regression in column 2
of Table 8. This coefficient is highly significant and implies a
substantially higher propensity to patent for firms with larger R&D
programs, with an elasticity of .25 at R&D of half a million rising
to over unity at R&D expenditures of one hundred million dollars.
The F—test for the industry dummies is now F(20,2557)3.5, implying
that there is very little difference in the average propensity to patent
across industries once we allow R&D to have a variable coefficient.—36—
This is a bit surprising and probably reflects the nonhomogeneity of
the firms in our industry classes and the problems associated with
assigning each firm to one and only one industry. The industries
which have coefficients significantly different from the average are the
petroleum industry (patenting 30% higher on average), engines, farm and
construction machinery (28%), conglomerates (767.), and computers
(20% less on average). We reestirnated the equation with no industry
dummies (column 3 of Table 8) and found that the slopes hardly changed;
this result held true for several different specifications of the model,
including one with only the log of R&D in the equation!°Although
we believe that there are significant differences in therelationship
of R&D and patenting at the detailed industry levelfrom inspection of
the distribution of the two variables by industry, thesedifferences
do not affect the basic results of thisaggregate study and we have
therefore omitted the industry dummies for the sake ofsimplicity in what
follows.
In the fourth column of Table 8 we add the log of thegross value
of the firm's plant to the regression to control for firmsize
independently of R&D expenditures. Larger firms may patent more often
simply because they are bigger and employ patent lawyers and otherpersonnel
solely for this purpose. The coefficient estimate for loggross plant lends
some support to this hypothesis, however, one should be careful in
interpreting the estimated size (assets) effects. To a significant extent
they may be just compensating for transitory and timing errors inour
R&D measure. The equation estimated assumes that this' year'spatents applied
for depends only on this year's R&D expenditures. We know that thisis—37—
not exactly correct (see Pakes andGriliches, this volume). Some of the
patents applied for are the result of R&Dexpenditures in years past while
not all of the R&D expenditures in thisyear will result in patents, even in
subsequent years. In this sense, the R&D variable issubject to significant
error which will be exacerbated oncewe control for size reducing thereby
the signal to noise ratio. Thismay explain both the reduction of the R&D
coefficient when assets are introducedas a separate variable and the rather
large estimated pure size effect. We cannot do muchabout this in this paper,
but we shall return to thistopic when we turn to the panel aspects of this
data set in later work.
We now turn to the Poisson formulation of the patents model.
This model treats the patents for each firm as arising from a Poisson
distribution whose underlying mean is given by exp(Xe) where XB is a
regression function of the independent variables in our model.
Coefficients estimated for this model are directly comparable to
those from a log patents regression; we have merely taken account of
the fact that the dependent variable is non—negative counts rather
than continuous. Bowever, for our data, we might expect the Poisson
formulation of the model to give quite different answers from a simple
log patents regression for two reasons: first, over half of our observation
on patents are zero and many are quite small, and second, the Poisson
objective function tends to give the largest observations more weight
than least squares on log patents and therefore these observations will
have more influence on the results. This is what we find in our results,
which are shown in column 2 of Table 9, together with the OLS estimates
for comparison. The ordinary least squares estimates imply an
elasticity of patenting with respect to R&D which rises
from zero at $100,000 of R&D to well above one at a billion dollars—38—
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of R&D. For the Poisson model on the other hand, the elasticity is one
at four million dollars of R&D and falls to one half at one billion dollars.
This is because the very largest firms do less patenting per R&D dollar
than would be predicted by a linear regression of log patents on log
R&D and they are having more influence' on the Poisson estimates than the
OLS. We show this graphically in Figure 5: what is plotted is the
predicted logarithm of patents versus the logarithm of R&D expenditures,
superimposed on the actual data. Clearly the differences in fit of the
models is most pronounced in the tails of the distribution.
As was pointed out by 1-lousman, Hall, and Griliches, the Poisson
model is highly restrictive, since it imposes a distribution on the data
whose mean is equal to its variance. This property arises from the
independence assumed for the Poisson arrival of "events" (patent applications)
and is unlikely to be true, even approximately, of our data. One way
out of this problem is the negative binomial model in which the Poisson
parameter is drawn from a gamma distribution with parameters exp(XB) and
6. We estimated such a model in the third column of Table 9 and found
that the results, although qualitatively closer to the ordinary least
squares estimates than to the Poisson, produce quite different predictions
over the range of the data and imply a lower and less varying elasticity
of patenting with respect to R&D. The range of elasticities is now
.55 at $100,000 in R&D to .66 at one billion dollars. A typical firm with
zero or missing R&D is predicted to have applied for 1.3 patents in 1976,




































































































































































































































































































































































































































A defect of the negative binomial model is that it imposes a specific
distribution, namely gamma, on the multiplicative disturbance. Unlike
the least squares case, if this distribution is wrongly specified,
the resulting maximum likelihood estimates nay be inconsistent. For this
reason and because of the large swings in our estimates under the models
we tried, we also estimated our model with nonlinear least squares using patents
as the dependent variable, which was proved by Gourieroux, Montfort,
and Trognon (1982) to be consistent for a wide class of Poisson—type models.
This produced the result shown in the last column of Table 9. The discrepancies
between these estimates and those of the Poisson model are a kind of
"specification" test, since both are consistent estimates of a large class
of count models with additive ormultiplicative disturbances. Our data,
however, have one feature which violates theassumptions of most of these
models: not only is the residual variance ofpatents larger than the mean,
but the ratio increases as the magnitude ofthe exogenous variables
(R&D) increases (see Hausman, Hall, and Griliches(1981)). This implies a
correlation between the X's in the model and thedisturbance which can
lead to inconsistent estimates of theslope parameters. Figure 5,
which displays the nonzero portion of the datadistribution with the
predictions for our various specificationssuperimposed, reveals that
in trying to impose a quadratic onour data to look for scale effects
we may mislead ourselves seriously because of thevery -large range of the
data and the peculiar distribution of thedependent variable. It appears
that the form we choose for the error distributionof the patents variable
will have a considerable effect on the results. Itshould be emphasized
that this result does not depend only on the large numberof zero observations—42—
in the data: we obtained qualitatively the same results when we reestirnated
including only those firms with both nonzero patents and R&D. -
Forboth these reasons, increasing variance with R&D and the difficulty
of choosing a proper functional form for both tails of the distribution
simultaneously, we chose to look at the interesting questions in this
data, which are the existence of a patenting threshold and the measurement
of returns to scale at the upper end of the R&D distribution, by dividing
the sample into two parts, using R&D as a the selection variable. To do
this, we first plotted the patents—R&D ratio for firms with both patents
and R&D grouped by R&D size class as shown in Figure 6. This plot is
consistent with a patenting elasticity of considerably less than one up
to about one or two million dollars of R&D and an elasticity of about
one after that, with a hint of downturn at the upper end (above 100 million).
Accordingly, we divided our sample into two groups: those with R&D
greater than two million and those with R&D less than two million or
missing.
The coefficients of interest from estimates on the two groups of
firmsare shown in Table 10 and the differences between them are
striking. The small firms show both the features we might have expected:
the Poisson—type models all are quite different from OLS on log patents,
sincemost of these firms have less than five patents, and the estimates are
all much closer to each other, since the problem of inconsistencyarising
from the increasing variance of patents is considerably mitigated.Substantively,
there is no real evidence of curvature in the relationship of R&D and
patents at this end of the distribution and the elasticity of patenting
with respect to R&D is close to the earlier estimates for large firms,















































































































































































































































































































































































































































































Turning to the larger firms, as we might expect since therange of R&D
is about ten times that of the smaller firms, there isconsiderably more
variation in the estimates. The log patents regression estimates are
much closer to the others, since the integer nature of the patents data is
not much of a problem here. However, there does seem to be some evidence
of a decrease in the elasticity of patenting with respect to R&D for the
largest firms. The Poisson and nonlinear least squares estimates exhibit
increasing returns up to about 20—40 million dollars of R&D and then
start declining whereas the OLS and negative binomial estimates show
decreasing returns with a slightly higher elasticity than the smaller
firms throughout. It is clear, however that we have not really solved
the specification problem for these large firms. The predicted values
from these estimates exhibit nearly the same sensitivity to exactly how we
weight the observations as did those from the whole sample. Our tentative
conclusion is that there is nearly constant returns to scale in
patenting throughout the range of R&D above two million dollars,
with decreasing returns setting in some place above 100 million
dollars.—46—
VI.Conclusion
We began this paper with a question to which we can now
provide at least a partial answer. We have seen that research and
development is done across all manufacturing industries with much
higher intensities in such technologically progressive industries as
chemicals, drugs, computing equipment, communication equipment, and
professional and scientific instruments. We have found an elasticity
of R&D with respect to sales of close to unity, but we also found
significant non—linearity in the relationship, implying that both very
small and very large firms are more R&D intensive than average size
firms.1' This effect remained afteran attempt to account for the
(possibly) non—random selection of the dependent variable, although the
lack of an exclusion restriction in this procedure casts some doubt
on the completeness of this correction. We also found evidence of
complementarity between capital intensity and R&D intensity, which
was increased when we corrected for the selectivity of R&D.
These results are contrary to the preponderance of previous work
on the size—R&D intensity relationship.12 Ramberg (1964) and Comanor (1967)
found a weakly decreasing relationship between R&D intensity and firm size.
Scherer (l965a) found that R&D intensity increased with firm size up to an
intermediate level, and then decreased, except in the chemical and petroleum
industries, in which it increased throughout. This has been interepreted
to imply, for most industries, a threshold size necessary before R&D is
performed, presumably because of fixed costs in performing R&D (Kamien
and Schwartz (1975)). As noted above, our results suggest the opposite,
though the selectivity issue precludes a definitive conclusion. In any—47—
case, these data cast strong doubt on the existence of any significant
R&D threshold!3
There are several possible reasons for these conflicting results.
First, earlier studies were based on smaller samples of larger companies,
of the Fortune 500 variety. An attempt was made to approximate these
samples by estimating equation (3) of Table 6 on those firms with sales
of $500 million or more (256 observations). This regression indicates
that this sample difference is not the source of the discrepancy; the
relationship was close to linear with an implied elasticity of R&D with
14 respect to sales of 1.23 at sales of $1 billion.
In addition, our R&D variable is an expenditure variable, whereas
much of the previous work used the nunber of R&D employees. If R&D
expenditures per research employee rise fast enough with increasing
firm size, perhaps because of greater capital intensity of R&D, we
would expect the observed difference in the results. It is not possible,
with these data, to test this hypothesis.
Finally, it is possible that the size—R&D intensity relationship
15 has changed since the earlier work was done. Becuase this work
did not look at small firms at all, it would be sufficient to postulate
increased relative R&D intensity by the largest firms to reconcile their
results with ours. We hope that our examination of the time—series
component of this data set will shed some light on this question.
Turning to the second question in our title, we have found that some,
but not all of the firms which do R&D also patent, and that there is a
strong relationship between the two activities throughout our sample.
The small firms which do R&D tend to patent more per R&D dollar than—48—
larger firms, and firms with R&D programs larger than about one or two
million dollars have a nearly constant ratio of patenting to R&D
throughout the sample except for the firms with the very largest R&D
programs -
Previousresearch on the relationship of R&D and patenting, in
particular Scherer (1965), has tended to focus on the largest U.S. corporations.
Scherer found an elasticity of patenting with respect to R&D employment of
unity with a hint of diminishing returns at the highest R&D input intensity.
Our data do not contradict this result, but they do suggest that for these
larger firms the elasticity of patenting with respect to R&D may have
fallen slightly between 1955 and 1976. However, measurement issues cloud
this conclusion since we are relating contemporary R&D expenditures and
successful patent applications while Scherer looks at patents granted
and the number of R&D employees (lagged by four years). It is not
easy to say a priori which relationship will be most free of noise, and we
must wait for time series studies to give us a better reading on the
precise relationship of the two variables. Work thus far (Pakes and
Griliches (1981), Fakes (1981)) has shown a strong contemporaneous
relationship of R&D and patent applications, but also found a total
elasticity closer to one when lagged R&D is included.
These data also confirm and extend what others, including Scherer,
have observed: a higher output of patents per R&D dollar for smaller
fins. However, our results are for many more smaller firms than previously,
and they show much sharper decreasing returns both in the measured
elasticity and in the basic patents to R&D ratio. We also found that
for this sample it mattered very much whether we used a model and estimation
method which allowed for zero—valued observations.—49—
In looking at these results on smaller firms, however, it is
important to emphasize that although we include all manufacturing firms
in our sample, whether or not they do R&D or patent, there is another
kind of selectivity at work: for a smaller firm, whether or not it
appears on the Compustat file in the first place is a sign of success
of some sort, or of a need forcapital. The basic definition which
gets a firm into the sample (if it is not automatically included
due to being traded on a major stock exchange) is "commands sufficient
investor interest." One of the likely causes of interest is a successful
R&D program, and hence some patent applications. Thus we tend to
observe small firms only when they have become "successful",
whereas almost all large firms are publicly traded and will appear in
our sample whether or not they have been particularly successful
recently in research or innovation. We find it difficult to argue
purely from this data that small firms have a higher return to R&D
when we have reason to believe that only those whith are successful
at it are likely to be in our sample in the first place.
This is our first exploration of this rather large and rich data
set. We hope to focus in the near future on the time series characteristics
of these data. We expect to be able to construct a consistent set of data
for at least seven years (1972—1978) for over a thousand firms. This
should allow us to investigate more thoroughly some of these same questions
and also many other aspects of R&D and patenting behavior.References
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FOOTNOTES
+Thisis a revision of an earlier draft of this paper which waspresented
at the NEER Conference on R&D, Patents, and Productivity in Lenox,Massachusetts,
October 1981. That version contained preliminary results onpatenting in the
Drug and Computer industries which have been replaced in this revision bya
section on patenting in all manufacturing industries.
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1.This limitation is primarily for convenience; about 97% ofcompany—
sponsored R&D was performed in the manufacturing sector in 1976
(NSF, 1978). It does, however, exclude a few large performers of
R&D in the communications and computer service industries.
2. The vast majority of patents are owned by principal companies. In
our earlier sample about ten percent of total patents were accounted
for by patents of subsidiaries.
3. The "not significant" code is a 1977 Compustat innovation which appears
in 1976 data only for the Full Coverage tape companies.
4. Or, more recently "not significant". See previous note.
5.Also included in "missing", are companies that reported R&D but
Compustat concluded that their definition of R&D did not conform.6. This comparison of the definitions in the twosurveys is drawn from
a letter detailing the differences from Milton Eisen, Chief, Industry
Division, Bureau of the Census, to Hr. William L. Stewart, R&D
Economic Studies Section, Division of Science Resources Studies,
National Science Foundation, in April 1978.
7. Leamer (1978) suggests using critical values for this F—test based
on Bayesian analysis with a diffuse prior as a solution to the old
problem of almost certain rejection of the null hypothesis with a
sufficiently large sample. Using his formula (page 114), the 5% level
for this F—test is 7.8, implying that we would accept the hypothesis
of equal slopes in this data.
8.Average sales for reporting firms is $620 million, for non—reporting
firms, $240 million.
9. Scherer (1981), using data on 443 large industrial corporations comprising
59 percent of corporate patenting activity in the U.S., found an R&D cost per
patent of $588,000 for the period June 1976 through March 1977 (adjusted to
(annual basis).
10. We also looked at this question for two different size classes of firms:
above and below 100 million dollars in gross plant. We found that
the smaller firms had a lower R&D coefficient (.26 in contrast to .36)
and slightly less curvature. For these firms, the industry dummies
were completely insignificant, whereas they remained at about the same
level for the large firms.
11. It should be emphasized, however, that our finding of increasing
R&D intensity as firm size rises does not necessarily imply returns
to scale in research and development unless one assumes homogeneity
of some degree in the R&D production function (see Fisher and Temin
(1973 and 1979)).
12. See Kamien and Schwartz (1975) for a summary.13. These data also do not support the existence of a peculiar size—R&D
thtensity relationship in the chemical or petroleum industries.
14. The coefficients (standard errors) were log sales, 1.29 (.61),
log sales squared, —.008 (.038).
15. I-lamberg used 1960 data; Comanor used 1955 and 1960 data; Scherer
used 1955 data.Appendix A
Composition of Industry Classes
Industry Included SIC Groups
Food and Kindred Products 20
Textiles & Apparel 22, 23
Chemicals, excluding Drugs 28, excluding 2830, 2844
Drugs & Medical Instruments 2830, 2844, 3841, 3843
Petroleum Refining & Extraction 29
Rubber & Misc. Plastics 30
Stone, Clay, and Glass 32
Primary Metals 33
Fabricated Metal Products 34, excluding 3480
Engines, Farm & Construction Equipment 3510—3536
Office, Computers, & Accounting Equipment 3570, 3573
Other Machinery, not Electric 35, excluding 3510—3536, 357
Electric Equipment & Supplies 36, excluding 3650—3679
Communication Equipment 3650—3679
Motor Vehicles & Transportation Equipment 37, excluding 3720—3729,3760
Aircraft & Aerospace 3720—3729, 3760
Professional & Scientific Equipment 38, excluding 3841, 3843
Lumber, Wood & Paper 24, 25, 26
Miscellaneous Consumer Goods 21, 31, 3900—3989, 3480
Miscellaneous Manufacturers, N.E.C. 27, 3990